Showing results (231-240 of 6,006) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|May 2, 2006
Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cellsMathias Schmidt, Hans-Peter Hofmann, Karl Sanders, et al.
Molecular Cancer Therapeutics|May 2, 2006
Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinomaLaura RosanĂ², Francesca Spinella, Valeriana Di Castro, et al.
Molecular Cancer Therapeutics|May 2, 2006
Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damageChristopher M Sturgeon, Zachary A Knight, Kevan M Shokat, et al.
Molecular Cancer Therapeutics|May 2, 2006
Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3sigmaBaoguang Han, Han Xie, Qun Chen, et al.
Molecular Cancer Therapeutics|May 2, 2006
Construction of a novel DNA decoy that inhibits the oncogenic beta-catenin/T-cell factor pathwayYosuke Seki, Hirofumi Yamamoto, Chew Yee Ngan, et al.
Molecular Cancer Therapeutics|May 2, 2006
Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha deliveryRachana K Visaria, Robert J Griffin, Brent W Williams, et al.
Molecular Cancer Therapeutics|May 2, 2006
Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vectorHidetoshi Mima, Seiji Yamamoto, Makoto Ito, et al.
Molecular Cancer Therapeutics|May 2, 2006
Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutationsRonald A Lubet, Konstantin Christov, Ming You, et al.
Molecular Cancer Therapeutics|August 8, 2006
Discovery and characterization of inhibitors of human palmitoyl acyltransferasesCharles E Ducker, Lindsay K Griffel, Ryan A Smith, et al.
Pageof 601